Biotech Values

[iwfal]

HCV and interferon -

My money is aligned with Roche and GILD on this one.

We are aligned on our disagreement -g-

BTW - This does not mean that I think that Ifn has nothing but a bump free future. Worst case it might be just the difficult to treat patients - e.g. relapsed (which I expect to be a larger percentage of responders than for current SOC). But I think there is a good chance that it is more than that.